Many countries use external reference pricing to help determine drug prices. However, external reference pricing has received little attention in the US—perhaps because the US is often the first ...
The renewed debate over Most Favored Nation (MFN) drug pricing in the United States reflects a legitimate frustration: ...
A new study found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US when compared with prices in the United Kingdom, Japan and the Canadian province of Ontario.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results